[EN] MUSCARINIC M2-ANTAGONIST COMBINATIONS<br/>[FR] COMBINAISONS D'ANTAGONISTE MUSCARINIQUE M2
申请人:CHASE PHARMACEUTICALS CORP
公开号:WO2017147104A1
公开(公告)日:2017-08-31
A combination of a M2-receptor antagonist, a non-anticholinergic antiemetic agent, a muscarinic receptor antagonist consisting of a non-selective peripheral anticholinergic agent, and optionally an anticholinesterase inhibitor, to treat hypocholinergic disorders such as Alzheimer type dementia, schizophrenia, schizophrenia associated dementia, and schizoaffective disorders.